Cargando…

Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption

Osteoporosis is an enormous health problem caused by the imbalance between bone resorption and bone formation. The current therapeutic strategies for osteoporosis still have some limitations. Boldine, an alkaloid isolated from Peumus boldus, has been shown to have antioxidant and anti-inflammatory e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kun, Lv, Zheng-tao, Cheng, Peng, Zhu, Wen-tao, Liang, Shuang, Yang, Qing, Parkman, Virginia-Jeni Akila, Zhou, Chen-he, Jing, Xing-zhi, Liu, Hui, Wang, Yu-ting, Lin, Hui, Liao, Hui, Chen, An-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146032/
https://www.ncbi.nlm.nih.gov/pubmed/30271347
http://dx.doi.org/10.3389/fphar.2018.01046
_version_ 1783356332256002048
author Chen, Kun
Lv, Zheng-tao
Cheng, Peng
Zhu, Wen-tao
Liang, Shuang
Yang, Qing
Parkman, Virginia-Jeni Akila
Zhou, Chen-he
Jing, Xing-zhi
Liu, Hui
Wang, Yu-ting
Lin, Hui
Liao, Hui
Chen, An-min
author_facet Chen, Kun
Lv, Zheng-tao
Cheng, Peng
Zhu, Wen-tao
Liang, Shuang
Yang, Qing
Parkman, Virginia-Jeni Akila
Zhou, Chen-he
Jing, Xing-zhi
Liu, Hui
Wang, Yu-ting
Lin, Hui
Liao, Hui
Chen, An-min
author_sort Chen, Kun
collection PubMed
description Osteoporosis is an enormous health problem caused by the imbalance between bone resorption and bone formation. The current therapeutic strategies for osteoporosis still have some limitations. Boldine, an alkaloid isolated from Peumus boldus, has been shown to have antioxidant and anti-inflammatory effects in vivo. For the first time, we discover that boldine has a protective effect for the estrogen deficiency-induced bone loss in mice. According to the Micro-CT and histomorphometry assays, boldine conducts this protective effect through inhibiting bone resorption without affecting bone formation in vivo. Moreover, we showed that boldine can inhibit receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation via impairing the AKT signaling pathways, while SC79 (an AKT agonist) partially rescue this effect. In conclusion, our results suggest that boldine can prevent estrogen deficiency-induced osteoporosis by inhibiting osteoclastogenesis. Thus, boldine may be served as a novel therapeutic agent for anti-osteoporotic therapy.
format Online
Article
Text
id pubmed-6146032
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61460322018-09-28 Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption Chen, Kun Lv, Zheng-tao Cheng, Peng Zhu, Wen-tao Liang, Shuang Yang, Qing Parkman, Virginia-Jeni Akila Zhou, Chen-he Jing, Xing-zhi Liu, Hui Wang, Yu-ting Lin, Hui Liao, Hui Chen, An-min Front Pharmacol Pharmacology Osteoporosis is an enormous health problem caused by the imbalance between bone resorption and bone formation. The current therapeutic strategies for osteoporosis still have some limitations. Boldine, an alkaloid isolated from Peumus boldus, has been shown to have antioxidant and anti-inflammatory effects in vivo. For the first time, we discover that boldine has a protective effect for the estrogen deficiency-induced bone loss in mice. According to the Micro-CT and histomorphometry assays, boldine conducts this protective effect through inhibiting bone resorption without affecting bone formation in vivo. Moreover, we showed that boldine can inhibit receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation via impairing the AKT signaling pathways, while SC79 (an AKT agonist) partially rescue this effect. In conclusion, our results suggest that boldine can prevent estrogen deficiency-induced osteoporosis by inhibiting osteoclastogenesis. Thus, boldine may be served as a novel therapeutic agent for anti-osteoporotic therapy. Frontiers Media S.A. 2018-09-13 /pmc/articles/PMC6146032/ /pubmed/30271347 http://dx.doi.org/10.3389/fphar.2018.01046 Text en Copyright © 2018 Chen, Lv, Cheng, Zhu, Liang, Yang, Parkman, Zhou, Jing, Liu, Wang, Lin, Liao and Chen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Chen, Kun
Lv, Zheng-tao
Cheng, Peng
Zhu, Wen-tao
Liang, Shuang
Yang, Qing
Parkman, Virginia-Jeni Akila
Zhou, Chen-he
Jing, Xing-zhi
Liu, Hui
Wang, Yu-ting
Lin, Hui
Liao, Hui
Chen, An-min
Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption
title Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption
title_full Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption
title_fullStr Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption
title_full_unstemmed Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption
title_short Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption
title_sort boldine ameliorates estrogen deficiency-induced bone loss via inhibiting bone resorption
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146032/
https://www.ncbi.nlm.nih.gov/pubmed/30271347
http://dx.doi.org/10.3389/fphar.2018.01046
work_keys_str_mv AT chenkun boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT lvzhengtao boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT chengpeng boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT zhuwentao boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT liangshuang boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT yangqing boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT parkmanvirginiajeniakila boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT zhouchenhe boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT jingxingzhi boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT liuhui boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT wangyuting boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT linhui boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT liaohui boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption
AT chenanmin boldineamelioratesestrogendeficiencyinducedbonelossviainhibitingboneresorption